CeriBell, Inc. (CBLL)
NASDAQ • Healthcare
Last close at October 26, 2026 at 20:00 UTC
Metrics Over Time
Where the Money Goes
Q2 2026In plain terms: out of every $100 in revenue, CeriBell, Inc. currently loses $69.
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
Nov 3
in 7 daysQ4 2026% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
CeriBell trailed consensus on EPS but topped revenue expectations in the second fiscal quarter of 2026, reported August 10, 2026, as revenue rose 32.5% to about $28.1 million (up from $21.2 million a year ago). Revenue of $28.1 million topped the $27.3 million estimate, +3%, while EPS of -$0.51 trailed the -$0.47 estimate (difference -$0.04) and was down from -$0.38 a year ago. Profitability stayed characterized by high gross margin and deeply negative operating leverage, with gross profit of roughly $25.9 million translating to a gross margin of ~92.3%, while operating income was about -$20.0 million for an operating margin of -71.1%. Net income was roughly -$19.3 million, down 41.2% year over year from -$13.6 million, and operating cash flow was negative at about -$12.9 million. Consensus for the next period calls for EPS of -$0.50 on revenue of $29.2 million.
Next report — what to expect
CeriBell, Inc. (CBLL) is scheduled to report earnings on November 3, 2026. Wall Street’s next-period consensus calls for EPS of -$0.50 on revenue of $29.2 million. For trailing context, revenue rose +32.5% year over year last quarter. CBLL has beaten EPS in 4 of its 8 most recent quarters.
About CeriBell, Inc.
CeriBell, Inc. trades on the NASDAQ as CBLL and makes neurodiagnostic equipment for the healthcare market, centered on AI-powered electroencephalography used at the patient's bedside. In FY2025, the company generated $89.1 million in revenue from its platform, accessories, and related devices for immediate diagnosis and treatment of neurological conditions.
Today's Snapshot
CBLL is trading slightly higher at 27.04, in line with a flat sector. So far today, CBLL is within 3.8% of its 52-week high of 28.11. Earnings are due from CBLL on 3 November.
Trading Volume
Below 10d avg (542.7K)
362.6K
vs S&P 500 Today
Underperforming Market
-0.62%
Updated: October 27, 2026 at 16:46 UTC
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$21.25 - $26.65Buy
- RSI (14)58.82Neutral
- Stochastic %K (14, 3, 3)80.97Sell
- MACD Level (12, 26)0.88Buy
Peers & Related Assets
Get premium market insights delivered directly to your inbox.